Psyence Net Debt from 2010 to 2024

PBMWW Stock   0.01  0.0006  7.50%   
Psyence Biomedical Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Psyence Biomedical Ltd minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2010-12-31
Previous Quarter
9.7 M
Current Value
10.2 M
Quarterly Volatility
5.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Psyence Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psyence Biomedical's main balance sheet or income statement drivers, such as Interest Income of 1.4 K, Selling General Administrative of 1.8 M or Selling And Marketing Expenses of 84.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 0.0 or Days Sales Outstanding of 0.0. Psyence financial statements analysis is a perfect complement when working with Psyence Biomedical Valuation or Volatility modules.
  
Check out the analysis of Psyence Biomedical Correlation against competitors.

Latest Psyence Biomedical's Net Debt Growth Pattern

Below is the plot of the Net Debt of Psyence Biomedical Ltd over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Psyence Biomedical's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Psyence Biomedical's overall financial position and show how it may be relating to other accounts over time.
Net Debt10 Years Trend
Slightly volatile
   Net Debt   
       Timeline  

Psyence Net Debt Regression Statistics

Arithmetic Mean(2,364,562)
Coefficient Of Variation(216.84)
Mean Deviation3,505,100
Median(4,754,403)
Standard Deviation5,127,312
Sample Variance26.3T
Range15M
R-Value0.69
Mean Square Error14.9T
R-Squared0.47
Significance0
Slope787,905
Total Sum of Squares368.1T

Psyence Net Debt History

202410.2 M
20239.7 M
2022-1.3 M
2021-1.8 M

Other Fundumenentals of Psyence Biomedical

Psyence Biomedical Net Debt component correlations

About Psyence Biomedical Financial Statements

Psyence Biomedical investors use historical fundamental indicators, such as Psyence Biomedical's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Psyence Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Debt9.7 M10.2 M
Net Debt To EBITDA(0.21)(0.20)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Psyence Stock Analysis

When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.